German Merck finally gets yes for MS drug Mavenclad

German Merck finally gets yes for MS drug Mavenclad

Source: 
Biopharma Dive
snippet: 

The FDA approved the drug under a comparatively restrictive label, however, likely meaning the market opportunity for German Merck is small.